LARIMAR THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $64.4M | $70.1M |
| FY2022 | — | $110.9M | $26.8M |
| FY2023 | — | $81.7M | $26.7M |
| FY2024 | — | $171.8M | $33.2M |
| FY2025 | — | $78.1M | $85.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $64.4M | $70.1M |
| FY2022 | — | $110.9M | $26.8M |
| FY2023 | — | $81.7M | $26.7M |
| FY2024 | — | $171.8M | $33.2M |
| FY2025 | — | $78.1M | $85.4M |